Explainer
The Biological Mechanism of Red Light Therapy: Why Cytochrome c Oxidase and Dosing Dictate Results
6 sources · 5d ago
Pain Management
Study Finds Non-Opioid Drug Journavx Prescribed Off-Label for Chronic Pain More Often Than Opioids
6 sources · 10d ago
Obesity Therapeutics
Phase 3 Data for 'Trillion-Dollar' Retatrutide Spurs FDA Warning Against Expanding Gray Market for Unapproved Drug
7 sources · 16d ago
More in Biohacking
ExplainerRegulatory Policy
How the FDA Uses AI to Identify Drug Responders in Landmark Regulatory Shift
Regulatory Innovators 40%Clinical Data Scientists 35%Traditional Diagnosticians 25%
3 sources · 21d ago
ExplainerImmune Aging
Study Finds Adult Thymus is Not 'Defunct,' Plays Profound Role in Longevity and Cancer Defense
Immunologists & Oncologists 40%Cardiothoracic Surgeons 35%Longevity Researchers 25%
8 sources · 32d ago
Epigenetic ReprogrammingClinical Trial Explainer
First Human Dosed With Cellular Reprogramming Injection in Landmark 'Reverse-Aging' Trial
Longevity Advocates 40%Cautious Biologists 35%Biotech Investors 25%
6 sources · 33d ago
Genetic MedicineBreakthrough Explainer
First In-Vivo CRISPR Therapy Achieves Phase 3 Success, Curing Hereditary Angioedema in 62% of Patients
Clinical Researchers 35%Biotech Industry & Investors 35%Patient Advocacy & Medical News 30%
8 sources · 35d ago
ExplainerMedical Breakthrough
Genetically Modified Pig Organs Successfully Transplanted into Humans, Ending Decades-Long Xenotransplantation Barrier
Transplant Surgeons & Researchers 45%Waitlist Patients & Advocates 35%Bioethicists & Animal Welfare Advocates 20%
3 sources · 40d ago
Genetic MedicineBreakthrough Explainer
World's First Bespoke CRISPR Therapy Cures Infant With Rare Genetic Disease, Paving Way for 'N-of-1' Medicine
Clinical Innovators 40%Biotech & Manufacturing 35%Patient Advocates 25%
2 sources · 51d ago
ExplainerLongevity Regulation
FDA and CMS Open Historic Dialogue on Regulating Aging as a Treatable Condition
Longevity Biotech Founders 40%Regulatory Pragmatists 35%Health Equity Advocates 25%
3 sources · 55d ago
Peptide RegulationExplainer
The Evidence Pack: How an Imminent FDA Hearing Will Decide the Fate of BPC-157 and TB-500
Biohackers & Longevity Advocates 40%Regulatory & Safety Officials 35%Compounding Pharmacists 25%
2 sources · 57d ago
Epigenetic ReprogrammingClinical Trial
First Human Trial of Cellular Reprogramming Drug Begins, Targeting Age Reversal in the Optic Nerve
Longevity Biotech Advocates 45%Clinical Ophthalmologists 35%Safety & Regulatory Monitors 20%
3 sources · 57d ago
Precision OncologyExplainer
Landmark Trial: Eli Lilly Drug Slashes Early-Stage Lung Cancer Recurrence Risk by 83%
Clinical Oncologists 45%Patient Advocates 35%Pharmaceutical Industry 20%
3 sources · 61d ago
Biohacking LimitsMedical Explainer
Biohacker Bryan Johnson Diagnosed With 'Incurable' Autoimmune Gastritis
Medical Realists 45%Longevity Optimists 30%Autoimmune Patient Advocates 25%
3 sources · 52d ago
ExplainerMetabolic Health
Why Continuous Glucose Monitors Became the Defining Wellness Tech of 2026
Metabolic Optimization Advocates 40%Traditional Medical Skeptics 30%Public Health Officials 30%
4 sources · 78d ago
ExplainerLongevity Science
Experimental 'Exercise Mimetic' Drug Shows Promise in Early Human Trials
Longevity Researchers 45%Metabolic Specialists 35%Clinical Skeptics 20%
3 sources · 80d ago
CRISPR MilestoneExplainer
Single-Dose In-Vivo CRISPR Therapy Achieves World's First Phase 3 Win, Validating Gene Editing Platform
Gene Editing Researchers 38%HAE Patient Advocates 38%Biotech Analysts 25%
3 sources · 56d ago
ExplainerPeptide Therapy
How Peptides Moved From Underground Biohacking to Mainstream Medicine
Longevity & Telehealth Advocates 40%Regulatory & Safety Watchdogs 35%Compounding Pharmacy Industry 25%
4 sources · 87d ago
Genetic MedicineExplainer
A New 'Base Editing' Technique Corrects Genetic Diseases in Human Embryos Without CRISPR's Damage
Genetic Researchers & Innovators 45%Bioethicists & Religious Objectors 30%Scientific Watchdogs & Safety Advocates 25%
4 sources · 87d ago
ExplainerMetabolic Health
Why Millions of Non-Diabetics Are Wearing Continuous Glucose Monitors
Metabolic Optimizers 44%Clinical Traditionalists 33%Diabetes Advocates 22%
3 sources · 91d ago




















